首页> 外文OA文献 >Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy

【2h】

Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy

机译：人铜转运蛋白1（HCTR1）患者III期非小细胞肺癌患者的预测和预测值，接受一线铂类双胞胎化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Helen H.W. Chen; Jiang-Jou Yan; Wen-Chung Chen; Macus Tien Kuo; Yu-Hsuan Lai; Wu-Wei Lai; Hsiao-Sheng Liu; Wu-Chou Su;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy [J] . ChenH.H.W., YanJ.-J., ChenW.-C., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2012,第2期

机译：人铜转运蛋白1（hCtr1）在III期非小细胞肺癌一线铂类双线化疗中的预测和预后价值
2. Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy. [J] . Yang CH, Yu CJ, Shih JY, Journal of Clinical Oncology . 2008,第16期

机译：特定的EGFR突变可预测接受一线吉非替尼单药治疗的初治非化疗非小细胞肺癌IIIB / IV期患者的治疗结果。
3. The safety and efficacy of gefitinib versus platinum-based doublets chemotherapy as the first-line treatment for advanced non-small-cell lung cancer patients in East Asia: a meta-analysis. [J] . Chang CH, Chen KY, Young-Xu Y, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2008,第2期

机译：吉非替尼相对于铂类双联化疗作为东亚晚期非小细胞肺癌患者的一线治疗的安全性和有效性：一项荟萃分析。
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients [D] . Pluta, Dustin. 2015

机译：基于预后和预测基因特征的亚组分析用于早期非小细胞肺癌患者的辅助化疗
6. Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy [O] . Helen H.W. Chen, Jiang-Jou Yan, Wen-Chung Chen, -1

机译：人铜转运蛋白1（HCTR1）患者III期非小细胞肺癌患者的预测和预测值接受一线铂类双胞胎化疗
7. Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial [O] . Solange Peters, Rolf A. Stahel, Urania Dafni, 2017

机译：随机的Erlotinib对多西紫杉醇的Arlotinib与多西紫杉醇的试验失败的一线铂类双细胞化疗，由Veristrat良好的veristrat差分层。欧洲胸肿瘤学平台（ETOP）重点肺试验

Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅